Curietherapies 2023: Advanced Targeting for Personalized Patient Care

At the end of this presentation, the participant will be able to:

• Analyse the adaptive benefits of several HDR implants 
• Explain the use of imaging at every step for a perzonalized brachytherapy implant

At the end of this presentation, the participant will be able to:

• Describe the commercially available applicators
• Explain the pros- and cons of such applicators
• Analyze the clinical and dosimetric benefits of a personnalized 3-D printed applicator

At the end of this presentation, the participant will be able to:

• Analyze the different implant techniques in regards to toxicity
• Discuss the need the need to limit treatment toxicity for stage IB-II tumors
• Discuss strategies to limit treatment toxicity.

At the end of this presentation, the participant will be able to:

• Enumerate the main steps of a cervical implant
• Discuss the benefit of a good workflow
• Review their own workflow and optimise it

At the end of this presentation, the participant will be able to:

• Explain the organ preservation using vulvar brachytherapy
• Discuss the morbidity and toxicity of available treatments
• Personalize the implant to the tumor and patient anatomy

At the end of this presentation, the participant will be able to understand the patient's experience. 

At the end of this presentation, the participant will be able to :

• Discuss difficult cases of GYN brachytherapy

At the end of this presentation, the participant will be able to

• Determine the need for a program implantation
• Understand the principles behind program implantation
• Discuss the challenges of a starting program

At the end of this presentation, the participant will be able to:

• List the steps needed to complete the program implantation (machine acquisitation, commisioning, sterilisation, etc..)
• Anticipate and avoid impediments in the day to day workflow

At the end of the presentation, the participant will be able to:

• Understand the needs of a QA program
• Describe the different tests needed in a QA program
• Explain the role of each contributor

At the end of this presentation, the participant will be able to:

• Discuss the first sites treated
• Analyze the encountered difficulties
• Avoid pitfalls

At the end of this presentations, the participant will be able to

• Discuss the cost of brachytherapy per site
• Compare this cost to external beam techniques

• 13:10
• 13;20
• 13:30
• 13:40

At the end of this talk, the participant will be able to

• Describe how a scintillator work
• Discuss the advantage of using scintillators in clinical
• Understand the limits of using such devises

At the end of the talk, the participant will be able to

• Discuss the benefit of autocontouring of target in GYN brachytherapy
• Explain the limits of using autocontouring
• Review their workflow to account for automated contouring

Each workshop lasts 1 hour. There will be a maximum of 10 participants per mini-Worshop. 

At the end of the presentation, the participant will be able to:

• List the different occular tumors amenable to brachytherapy
• Discuss the use of brachytherapy in this context
• Analyze technique and dosimetric parameters

At the end of the presentation, the participant will be able to:

• List the different localizations amenable to brachytherapy
• Discuss the use of brachytherapy in this context
• Analyze technique and dosimetric parameters

At the end of the presentation, the participant will be able to:

• List the different renal tumors amenable to brachytherapy
• Discuss the use of brachytherapy in this context
• Analyze technique and dosimetric parameters

At the end of the presentation, the participant will be able to:

• List the different localizations amenable to brachytherapy
• Discuss the use of brachytherapy in this context
• Analyze technique and dosimetric parameters

At the end of the presentation, the participant will be able to:

• List the different localizations amenable to brachytherapy
• Discuss the use of brachytherapy in this context
• Analyze technique and dosimetric paramet

At the end of this presentation, the participant will be able to:

• List the toxicities of GYN brachytherapy
• Discuss how these changes can affect sexual function
• Explain the use of standardized questionnaires in this context
• Discuss strategies to improve sexual function after treatment

At the end of this presentation, the participant will be able to:

• List the toxicities of breast brachytherapy
• Discuss how these changes can affect sexual function and quality of life
• Discuss strategies to improve sexual function after treatment

At the end of this presentation, the participant will be able to:

• List the toxicities of H&N brachytherapy
• Discuss the effect of theses toxicities on quality of life
• Relate these toxicities to body-image

At the end of this presentation, the participant will be able to:

• Analyze the use and the duration of androgen deprivation therapy
• Discuss the benefits of brachytherapy in the absence of OS benefit
• Analyze the toxicitites related to the optimal treatment

At the end of this presentation, the participant will be able to:

• Explain the study protocol
• Analyze the preliminary results

At the end of this presentation, the participant will be able to:

• Define a PSA bouce
• Determine when to evaluate and treat patients after a PSA rise
• Analyze the possibility of a relationship between a PSA bounce a a recurrence. 

At the end of this presentation, the participant will be able to:

• Disucss the kinetics of PSA values post-brachytherapy
• Determine the optimal lowest PSA value after prostate brachytherapy
• Analyze the relationship between PSA nadir and prostate cancer recurrence

At the end of this presentation, the participant will be able to:

• Explain the planning steps for an intra-op prostate HDR implant
• Discuss the different ways to achive contouring automation
• Analyze the gain of introducing automation of target contouring

At the end of this presentation, the participant will be able to:

• List the different functional imaging modalities available
• Explain the clinical added value of such mdalities

At the end of this presentation, the participant will be able to:

• Compare brachhytherapy and SBRT techniques in regards to toxicity, cost, and clinical results

Score Keeper and referee: Marjory Jolicoeur

Debating cons: Lun Beaulieu

Debating pros: Gerard Morton